CD5 CAR T-cells Clinical Trials

2 actively recruiting trials

Also known as: CD5+ T-ALL Targeted CAR T-cells injection, CD5+ T-lymphoma Targeted CAR T-cells injection

Pipeline

Early 1: 2

Top Sponsors

Zhejiang University2

Indications

Cancer2
T Acute Lymphoblastic Leukemia1
T-lymphoblastic Lymphoma1

Other2 trials

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

Early 1

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.